Induction of heme oxygenase-1 during endotoxemia is downregulated by transforming growth factor-β1

Circulation Research

Volumn 83, Issue 4, 1998, Pages 396-403

  Pellacani, Andrea ^a   Wiesel, Philippe ^a   Sharma, Arunabh ^b,d   Foster, Lauren C ^a   Huggins, Gordon S ^a,b,c   Yet, Shaw Fang ^a   Perrella, Mark A ^a,b,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endotoxic shock; Enzyme activity; Gene expression; Vascular smooth muscle cell

Indexed keywords

ENDOTOXIN; HEME OXYGENASE; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; GENE EXPRESSION; HEMODYNAMICS; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0032563675     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.4.396     Document Type: Article

References (45)

1. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Donner RL, Cunnion RE, Ognibene FP. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113:227-242.
2. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471-1477.
3. Bone RC. The pathogenesis of sepsis. Ann Intern Med. 1991;115: 457-469.
4. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA. 1992;268:3452-3455.
5. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79: 319-326.
6. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ. Dinarello CA. Interleukin 1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 1988;81:1162-1172.
7. Epstein FH. The role of interleukin-1 in disease. N Engl J Med. 1993; 328:106-113.
8. Perrella MA, Yoshizumi M, Fen Z, Tsai J-C, Hsieh C-M, Kourembanas S, Lee M-E. Transforming growth factor-β1, but not dexamethasone. down-regulates nitric oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J Biol Chem. 1994;269: 14595-14600.
9. Perrella MA, Patterson C, Tan L, Yet S-F, Hsieh C-M, Yoshizumi M, Lee M-E. Suppression of interleukin-1β-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-β1 in vascular smooth muscle cells: evidence for mechanisms other than NF-κB. J Biol Chem. 1996;271:13776-13780.
10. Perrella MA, Hsieh C-M, Lee W-S, Shieh S, Tsai J-C, Patterson C, Lowenstein CJ, Long NC, Haber E, Shore S, Lee M-E. Arrest of endotoxin-induced hypotension by transforming growth factor-β1. Proc Natl Acad Sci USA. 1996;93:2054-2059.
11. Yet S-F, Pellacani A, Patterson C, Tan L, Folta SC, Foster L, Lee W-S, Hsieh C-M, Perrella MA. Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem. 1997;272:4295-4301.
12. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H, Mudgett JS. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995;81:641-650.
13. Wei X, Charles IG, Smith A, Ure J, Feng G, Huang F, Xu D, Muller W, Moncada S, Leiw FY. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 1995;375:408-411.
14. Koide M, Kawahara Y, Tsuda T, Yokoyama M. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 1993;318:213-217.
15. Kanno K, Hirata Y, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 1993; 22:34-39.
16. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
17. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770-774.
18. Böttinger EP, Letterio JJ, Roberts AB. Biology of TGF-β in knockout and transgenic mouse models. Kidney Int. 1997;51:1355-1360.
19. Wahl SM. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J Clin Immunol. 1992;12:61-74.
20. Junquero DC, Scott-Burden T, Schini VB, Vanhoutte PM. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-β1 in human smooth muscle cells. J Physiol (Lond). 1992;454: 451-465.
21. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A. 1995;92:10688-10692.
22. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;61:748-755.
23. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517-554.
24. Schacter BA. Heme catabolism by heme oxygenase: physiology, regulation, and mechanism of action. Semin Hematol. 1988;25:349-369.
25. Morita T, Perrella MA, Lee M-E, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A. 1995;92:1475-1479.
26. Cantoni L, Rossi C, Rizzardini M, Gadina M, Ghezzi P. Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase: feedback regulation by glucocorticoids. Biochem J. 1991;279:891-894.
27. Maines MD. Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim Biophys Acta. 1981;673: 339-350.
28. Zygmunt PM, Högestätt ED, Grundemar L. Light-dependent effects of zinc protoporphyrin IX on endothelium-dependent relaxation resistant to Nω-nitro-L-arginine. Acta Physiol Scand. 1994;152:137-143.
29. Gunther S, Alexander RW, Atkinson WJ, Gimbrone MA Jr. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol. 1982;92:289-298.
30. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989.
31. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest. 1995;96:2676-2682.
32. McCoubrey WK, Eke B, Maines MD. Multiple transcripts encoding heme oxygenase-2 in rat testis: developmental and cell-specific regulation of transcripts and protein. Biol Reprod. 1995;53:1330-1338.
33. Sun Y, Maines MD. Heme oxygenase-2 mRNA: developmental expression in the rat liver and response to cobalt chloride. Arch Biochem Biophys. 1990;282:340-345.
34. Lee M-E, Bloch KD, Clifford JA, Quertermous T. Functional analysis of the endothelin-1 gene promoter: evidence for an endothelial cell-specific cis-acting sequence. J Biol Chem. 1990;265:10446-10450.
35. Maines MD, Ibrahim NG, Kappas A. Solubilization and partial purification of heme oxygenase from rat liver. J Biol Chem. 1977;252: 5900-5903.
36. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 1992;267:18148-18153.
37. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature. 1988;334:260-262.
38. Chantry D, Turner M, Abney E, Feldmann M. Modulation of cytokine production by transforming growth factor-beta. J Immunol. 1989;142: 4295-4300.
39. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med. 1987;166:571-576.
40. Wahl SM, Costa GL, Corcoran M, Wahl LM, Berger AE. Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol. 1993;150:3553-3560.
41. Otterbein L, Sylvester SL, Choi AMK. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol. 1995;13:595-601.
42. Poss KJD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A. 1997;94:10925-10930.
43. Ingi T, Ronnett GV. Direct demonstration of a physiological role for carbon monoxide in olfactory receptor neurons. J Neurosci. 1995;15: 8214-8222.
44. Ingi T, Chiang G, Ronnett GV. The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci. 1996;16:5621-5628.
45. Kutty RK, Nagineni CN, Kutty G, Hooks JJ, Chader GJ, Wiggert B. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-β. J Cell Physiol. 1994; 159:371-378.